Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 351–400 of 1,032 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06922318	The COSMYC Trial (COmbined Suppression of MYC)	recruiting	Phase 2	50	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Jun 18, 2026	clinicaltrials
NCT07407582	Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)	recruiting	Phase 1 / Phase 2	25	University of ArizonaOTHER	1	Jun 18, 2026	clinicaltrials